Belzer UW Cold Storage Solution Recall: Updated Contamination Advice
Areazine synthesizes this MHRA medicine alert directly from MHRA's official public data feed. See our methodology for full source attribution and refresh cadence.
MHRA issues updated advice on contamination defects in Belzer UW® Cold Storage Solution and Belzer MPS® solutions for organ preservation manufactured by Carnamedica.
What this MHRA medicine alert tells you, and what most readers miss
This notice was issued by MHRA on August 6, 2026 and geographically references United Kingdom. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Medicine Alerts - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, mhra, medicine.
What Happened
The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs due to contamination of fluid. This DSI/2026/006 replaces advice in DSI/2023/005.
Which Products Are Affected
Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution) manufactured by Carnamedica (UKRP: Bridge to Life).
What You Should Do
Refer to the updated MHRA advice in DSI/2026/006 for current guidance.
Why This Matters
The solutions are used for the preservation of donated organs.
Source
MHRA Drug Device Alert - DSI/2026/006 (update to DSI/2023/005)
Original source: MHRA Official Notice ↗
Related Medicine Alerts
All Medicine Alerts →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this MHRA medicine alert: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (913 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 6, 2026.
Frequently Asked Questions
Common questions about this MHRA medicine alert.